Xenon Pharmaceuticals Inc. (XENE)
NASDAQ
Xenon Pharmaceuticals Inc. Net Income 2012–2025
Xenon Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2012 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Xenon Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -102.3 M, a 57.27% increase year-over-year.
- Xenon Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -343.0 M, a 66.65% increase year-over-year.
- Xenon Pharmaceuticals Inc. annual net income for 2025 was -345.9 M, a 47.62% increase from 2024.
- Xenon Pharmaceuticals Inc. annual net income for 2024 was -234.3 M, a 28.48% increase from 2023.
- Xenon Pharmaceuticals Inc. annual net income for 2023 was -182.4 M, a 45.48% increase from 2022.
- Xenon Pharmaceuticals Inc. annual net income for 2022 was -125.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Xenon Pharmaceuticals Inc. Net Income — FAQ
Xenon Pharmaceuticals Inc. (XENE) net income over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is Xenon Pharmaceuticals Inc.'s net income?
Xenon Pharmaceuticals Inc. (XENE) reported net income of -$346M for fiscal 2025.
Where can I see XENE's net income history?
The chart and table above show Xenon Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.